Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,986.91 million compared to CNY 1,984.31 million a year ago. Revenue was CNY 2,007.14 million compared to CNY 2,000.41 million a year ago.

Net income was CNY 412.78 million compared to CNY 398.2 million a year ago. Basic earnings per share from continuing operations was CNY 1.0258 compared to CNY 1.0055 a year ago. Diluted earnings per share from continuing operations was CNY 1.0258 compared to CNY 1.0055 a year ago.